-
Other
-
Resolution: Answered
-
Critical
-
None
-
None
-
Thank you for your inquiry for CMS249v5 (2023 performance period). The measure does not exclude patients who have had an esophageal biopsy.
-
CMS0249v6
-
CMS0249v5
-
we are unclear how to apply measure 249 codes to these specimens.
Measure 249 is described as being applied to esophageal biopsies. If a specimen is identified as a GE Junction biopsy, do we make this specimen an exclusion from the measure or do we consider this an esophageal specimen?